Pathway Diagnostics: Biomarker Development, Testing and Commercialization Ask Us How

Biomarker Reference Lab

Our CAP and CLIA accredited Biomarker Reference Laboratory represents an intermediate step in the biomarker commercialization process and performs only a select group of biomarker assays. Pathway Diagnostic's partners can utilize our Biomarker Reference Laboratory as an intermediate service during the process of transferring and validating our proprietary assays in their own laboratories. This unique approach accelerates market development for these biomarkers, enhancing assay value for our partners. Along with our partners, we gain significant insight into how physicians can incorporate these biomarker assays into standard patient care.

What's New "Announcing SensiTrop™ II HIV co-receptor tropism assay, combining the sensitivity of heteroduplex tracking and the specificity of DNA sequence analysis "
©2007 PathwayDX.com. Privacy Policy.